Loading...
机构名称:
¥ 1.0

(1) https://www.globaldata.com/media/pharma/glp-1r-agonists-type-2-diabetes-obesity-market-reach-125-billion-7mm-2033-forecasts-globaldata/ (2) https://www.jpmorgan.com/insights/global-research/current-events/obesity-drugs (3) https://www.wsj.com/health/pharma/ozempic-is-take-off-with-the-worlds-largest-obese-population-hint-it-isnt-the-us-a7c2498c (4) https://www.globaldata.com/media/business-fundamentals/top-20-global-biopharmaceutical-companies-report-4-3-growth-in-market-capitalization-in-q2-2024-reveals-globaldata/

将增长战略付诸行动 iX Biopharma Ltd ...

将增长战略付诸行动 iX Biopharma Ltd ...PDF文件第1页

将增长战略付诸行动 iX Biopharma Ltd ...PDF文件第2页

将增长战略付诸行动 iX Biopharma Ltd ...PDF文件第3页

将增长战略付诸行动 iX Biopharma Ltd ...PDF文件第4页

将增长战略付诸行动 iX Biopharma Ltd ...PDF文件第5页